Steven Vassallo, a director at $CBRS, sold 16,671 shares of the company on 08-14-2026 for an estimated $3,625,442. We received data on the trade from a recent SEC filing. This was a sale of approximately 17.8% of their shares of this class of stock. Following this trade, they now own 76,847 shares of this class of $CBRS stock.
$CBRS Insider Trading Activity
$CBRS insiders have traded $CBRS stock on the open market 135 times in the past 6 months. Of those trades, 0 have been purchases and 135 have been sales.
Here’s a breakdown of recent trading of $CBRS stock by insiders over the last 6 months:
- DHIRAJ MALLICK (Chief Operating Officer) has made 0 purchases and 58 sales selling 79,445 shares for an estimated $14,117,476.
- STEVEN VASSALLO has made 0 purchases and 5 sales selling 50,000 shares for an estimated $10,909,101.
- ANDREW D. FELDMAN (CEO, President) has made 0 purchases and 12 sales selling 17,990 shares for an estimated $3,113,282.
- YAGNESH PATEL (Chief Accounting Officer) has made 0 purchases and 44 sales selling 10,079 shares for an estimated $1,739,513.
- SEAN LIE (Chief Technology Officer) has made 0 purchases and 16 sales selling 10,033 shares for an estimated $1,706,311.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CBRS Hedge Fund Activity
We have seen 390 institutional investors add shares of $CBRS stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECLIPSE OPERATIONS, LLC added 11,446,270 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,529,625,670
- FMR LLC added 8,435,095 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,864,155,995
- COATUE MANAGEMENT LLC added 7,011,028 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,549,437,188
- CAPITAL WORLD INVESTORS added 3,894,458 shares (+inf%) to their portfolio in Q2 2026, for an estimated $860,675,218
- MORGAN STANLEY added 3,224,209 shares (+inf%) to their portfolio in Q2 2026, for an estimated $712,550,189
- ATREIDES MANAGEMENT, LP added 3,110,086 shares (+inf%) to their portfolio in Q2 2026, for an estimated $687,329,006
- JPMORGAN CHASE & CO added 3,100,806 shares (+inf%) to their portfolio in Q2 2026, for an estimated $685,278,126
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CBRS Analyst Ratings
Wall Street analysts have issued reports on $CBRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 06/08/2026
To track analyst ratings and price targets for $CBRS, check out Quiver Quantitative's $CBRS forecast page.
$CBRS Price Targets
Multiple analysts have issued price targets for $CBRS recently. We have seen 11 analysts offer price targets for $CBRS in the last 6 months, with a median target of $300.0.
Here are some recent targets:
- Paul Meeks from Freedom Capital Markets set a target price of $209.0 on 06/30/2026
- N. Quinn Bolton from Needham set a target price of $300.0 on 06/24/2026
- Matt Bryson from Wedbush set a target price of $280.0 on 06/24/2026
- Joseph Moore from Morgan Stanley set a target price of $273.0 on 06/24/2026
- Kevin Cassidy from Rosenblatt set a target price of $300.0 on 06/24/2026
- Timothy Arcuri from UBS set a target price of $320.0 on 06/24/2026
- Richard Shannon from Craig-Hallum set a target price of $325.0 on 06/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
